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Abstract 
Persistent severe fatigue is highly prevalent in cancer survivors and has long-term negative 
effects. This study’s purpose is to examine the effectiveness of evidence-based Cognitive 
Behavioral Therapy (CBT) in reducing post-cancer fatigue in clinical practice. The 
effectiveness of CBT is based on the assumption that cancer and its treatment trigger the 
experience of fatigue, but cognitive and behavioral factors are contributing to the persistence 
of the fatigue.  
Forty three cancer survivors with severe chronic fatigue that fulfilled the criteria for 
undifferentiated somatoform disorder (DSM-IV) and received CBT at the Helen Dowling 
Institute participated in the study. A quasi-experimental one-group pre-test post-test design 
was used to assess fatigue severity, functional impairment and psychological distress using 
the Checklist Individual Strength fatigue severity subscale, RAND-36 and Hospital Anxiety 
and Depression Scale. 
Clients reported a significantly greater decrease in fatigue severity, functional 
impairment and psychological distress after therapy. Clinically significant improvement was 
seen in 14% of the clients. CBT in clinical practice seems effective in reducing post-cancer 
fatigue, as fatigue severity reduced more among clients in clinical practice than clients in the 
RCT waiting list condition. However, the effect of the intervention in clinical practice was 
less than the intervention in the RCT. Further research should focus on the effect of therapist 
drift in explaining the differences between the RCT and clinical practice and the long-term 
effects of the intervention, as RCT results can not be generalized to clinical practice because 
it controls variables and circumstances that can not be controlled in clinical practice.  
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1. Introduction 
Cancer-related fatigue (CRF) is defined by the National Cancer Comprehensive Network 
(NCCN; 2014) as: “a distressing, persistent, subjective sense of physical, emotional and/or 
cognitive tiredness or exhaustion related to cancer or cancer treatment that is not proportional 
to recent activity and interferes with usual functioning” (p. 22). It occurs during treatment, in 
advanced phases of the disease and after curative treatment (Whitehead, Unahi, Burrell & 
Crowe, 2016). As CRF describes fatigue both during and after treatment, the term post-cancer 
fatigue will be used when referred to CRF after treatment. During treatment, severe fatigue as 
one of the main symptoms is reported by 25% to 75% in different kinds of cancer. It is 
accepted by clinicians that this is related to chemotherapy, hormonal therapy, radiotherapy 
and surgery (Servaes et al., 2002). This number declines after treatment to approximately one 
third of the survivors, with 36% suffering from moderate fatigue and 12% from severe 
fatigue (Kuhnt et al., 2009). In the Netherlands, 156.000 cancer survivors suffer from fatigue 
(Goedendorp, Gielissen, Verhagen & Bleijenberg, 2013). Due to increasing survival rates, 
this number is expected to rise in the upcoming years (Meulepas, Kiemeney & Benraadt, 
2011). Among this group of patients who experience post-cancer fatigue, it is reported to be 
the most distressing symptom and 91% mentioned that it interfered with living a normal life 
(Servaes,Verhagen & Bleijenberg, 2002). Severe fatigue is defined as a score of 35 or higher 
on the Checklist Individual Strength fatigue severity subscale, based on previous research 
with Chronic Fatigue Syndrome patients (Servaes et al., 2002). Post-cancer fatigue can 
persist for many years after treatment (Bower et al., 2005). Spontaneous recovery of fatigue 
severity hardly occurs, as shown in studies with waiting list control groups (Bower et al., 
2015; Johns et al., 2015; Gielissen et al., 2006; Kreissl et al., 2016).  
According to the Fatigue Coalition, CRF has to meet six out of eleven criteria from 
which at least one of them is the presence of fatigue. These symptoms need to be present for 
at least two weeks in the last month, are a consequence of the disease or treatment and cause 
clinically significant distress or functional impairment that is not caused by a comorbid 
psychiatric condition (Murphy, Alexander & Stone, 2006). The fatigue-related symptoms 
include “(1) significant fatigue, diminished energy or increased need to rest, disproportionate 
to any recent change in activity level (2) complaints of generalized weakness or limb 
heaviness (3) diminished concentration or attention (4) decreased motivation or interest in 
engaging in usual activities (5) insomnia or hypersomnia (6) experience of sleep as 
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unrefreshing or nonrestorative (7) perceived need to struggle to overcome inactivity (8) 
marked emotional reactivity (e.g., sadness, frustration, or irritability) to feeling fatigued (9) 
difficulty completing daily tasks attributed to feeling fatigued (10) perceived problems with 
short-term memory (11) post-exertional malaise lasting several hours” (Murphy et al., 2006, 
p. 413).  
Much research has been done on contributing factors to the development of post-
cancer fatigue. The demographic factors age and gender are found to be significantly 
associated with fatigue. Female and older survivors suffer from fatigue more often and more 
severe (Kreissl et al., 2016; Miaskowski, 2004). Breast cancer survivors with a partner have a 
reduced risk for persistent severe fatigue compared to those without a partner (Abrahams et 
al., 2016). No influence has been found for other demographics, including ethnicity, 
education level and employment status (Abrahams et al., 2016; Kuhnt et al., 2009). With 
regard to disease- and treatment related factors, advanced stages of breast cancer and more 
aggressive treatments are found to be increasing the risk of fatigue (Abrahams et al., 2016; 
Gielissen et al., 2007). Although contradictory findings exist (Okuyama et al., 2000), it is 
found that patients who received only surgery and no adjuvant therapy and completed 
treatment in one month are at lower risk of persistent severe fatigue (Abrahams et al., 2016; 
Servaes, Gielissen, Verhagen & Bleijenberg, 2007). No other disease- and treatment-related 
factors are found to be influencing post-cancer fatigue, including type of diagnosis, size of 
the tumour, number of nodes involved, relapses, treatment duration and time after treatment 
(Abrahams et al., 2016; Kuhnt et al., 2009; Okuyama et al., 2000). A strong positive 
correlation is found between both anxiety and depression and intense fatigue after treatment 
(Kuhnt et al., 2009). An explanation might be that fatigue is a symptom of depression or 
anxiety, caused by lower quality of life or fear of relapse. However, persistent severe fatigue 
can also be the cause of depression or anxiety (Servaes et al., 2002). The link between 
depression and fatigue is complex and often raises the question whether depression and 
fatigue are the same phenomenon (Reuter & Härter, 2004). Yet, it is suggested that both 
overlap in symptoms, but can not be considered as the same (Kuhnt et al., 2009). Research so 
far shows that post-cancer fatigue is mostly determined by psychological and treatment 
factors. 
CRF is a multidimensional phenomenon, as it has a major impact on overall quality of 
life due to physical, cognitive, affective, behavioural, social and economic effects (Prue, 
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Rankin, Allen, Gracey & Cramp, 2006; Young & White, 2006). Severely fatigued disease-
free cancer patients experience many negative consequences. In a sample of severely fatigued 
disease-free breast cancer patients, eight dimensions are found on which these patients score 
significantly higher compared to non-fatigued patients; psychological distress, sleep 
disturbances, physical inactivity, functional impairment in daily life (e.g. role functioning, 
home management, work and recreation), reduced social functioning and less social support, 
neuropsychological impairment, dysfunctional cognitions and low self-efficacy (Servaes et 
al., 2002). While the direction remains unclear, some problems are influenced both ways, 
including physical activity (Servaes et al., 2002). Depression, physical inactivity, sleep during 
the day and causal attributions of the symptoms to fatigue severity are found to have a direct 
negative effect on fatigue intensity (Servaes et al., 2002). Next to that, CRF is associated with 
psychological impairment (Curt et al., 2000). Patients report having lower motivation levels, 
depression and disturbances in cognition. On economical level, both patients’ and primary 
caregiver’s ability to work decreases, which has a major impact on quality of life (Curt et al., 
2000).  
In attempts to reduce CRF, possible biomedical explanations have been studied. It is 
found to be related to the release of proinflammatory cytokines (Bower, Ganz, Aziz & Fahey, 
2002), a flatter diurnal cortisol rhythm and a less quick decrease of cortisol levels in the 
evening (Bower et al., 2005) and changes in the hypothalamic-pituitary-adrenal (HPA; 
Bower, Ganz & Aziz, 2005). Despite these biomedical explanations of persistent severe 
fatigue, there are many contradictory statements. Up till now, no medical treatment is 
available in reducing cancer-related fatigue (Gielissen et al. 2006). The absence of a medical 
treatment and the contributing psychological factors explain the focus on psychological 
interventions. The NCCN (2014) recommends psychosocial interventions for CRF that focus 
on changing the cognitive and behavioral reactions to the cancer-related stressors (Duijts et 
al., 2011). Effective interventions include exercise programs (Speck, Courneya, Mâsse, Duval 
& Schmitz, 2010), psychoeducation (Meneses et al., 2007) and mindfulness-based 
interventions (Bruggeman Everts, Van der Lee & de Jager Meezenbroek, 2015; Lengacher et 
al., 2009; Van der Lee & Garssen, 2012).  
 Another evidence-based intervention to reduce CRF is cognitive behavioral therapy 
(CBT). CBT is defined as “an action-oriented psychosocial therapy based on the cognitive 
model that assumes that maladaptive thinking patterns cause maladaptive behaviour and 
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emotions.” (Gale Encyclopedia of Medicine, 2008, p. 1). A large meta-analysis from Kangas, 
Bovbjerg and Montgomery (2008) conducted a review of 117 studies on non-
pharmacological interventions for CRF. Among the RCT studies that reported a CRF 
outcome, 26% of the CBT interventions were found to significantly reduce fatigue severity. 
Among the single-group design studies that used a CBT intervention, 67% was found to be 
effective. Overall, a moderate to large effect size is found for CBT interventions for CRF 
(Kangas et al., 2008). A randomized controlled trial (RCT) from Gielissen et al. (2006) 
reported the effectiveness of CBT specifically on post-cancer fatigue in cancer survivors. 
Despite the fact that CRF has to persist for at least two weeks according to the previously 
mentioned guidelines (Murphy et al., 2006), participants in this study were required to 
experience severe fatigue for at least six months. They received personalized therapy, which 
means the therapy is based on their needs according to the scores on several questionnaires. 
These questionnaires were used to determine the modules for the sessions and measured the 
constructs fear of disease recurrence, insufficient coping with the experience of cancer, 
dysfunctional cognitions concerning fatigue, dysregulation of sleep, dysregulation of activity 
and low social support and negative social interactions. After six months, the patients in the 
intervention condition scored significantly lower on fatigue severity, functional impairment 
and psychological distress compared to the patients in the waiting list condition. The 
effectiveness of CBT is based on the assumption that cancer as disease and its related 
treatment are triggers for the experience of cancer-related fatigue. However, the above 
mentioned constructs are contributing to the persistence of the fatigue. Therefore, these 
perpetuating factors should be the target of psychological treatment, including CBT 
(Gielissen et al., 2006). It is suggested that therapy should start from two months onwards 
after successful treatment, as at that point fatigue severity does not decrease and the 
perpetuating factors can be determined (Goedendorp et al., 2013). Besides, the significant 
long-term effects of CBT were confirmed in a two year follow-up study (Gielissen, Verhagen 
& Bleijenberg, 2007). Next to that, CBT for post-cancer fatigue is found to be effective in 
reducing cognitive impairment, which is experienced by many cancer survivors (Goedendorp, 
Knoop, Gielissen, Verhagen & Bleijenberg, 2014). However, the effectiveness of this 
evidence-based intervention has not been demonstrated yet in clinical practice. The 
intervention, which is based on the RCT of Gielissen et al. (2006), has been implemented at 
the Helen Dowling Institute. The current research will examine the effectiveness of CBT on 
post-cancer fatigue in clinical practice.  
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Moreover, the effects of CBT in this study will be compared to the effects of the RCT 
(Gielissen et al., 2006). This design is considered the gold standard in research to the efficacy 
of psychological interventions (Bath, Delfino & Künzler, 2013). Protocols composed in 
RCT’s are supposed to prevent unsuitable treatment and increase efficiency. However, there 
are many reasons why evidence-based interventions are often less effective in clinical 
practice. Therapists can be insufficiently trained in delivering therapy according to the 
treatment manual or the work setting does not allow the necessary methods to be applied 
(Waller, 2009; Waller & Turner, 2016). Yet, even if the necessary resources are present, 
therapist can fail to deliver the adequate intervention due to therapist drift. “Therapist drift 
occurs when clinicians fail to deliver the optimum evidence-based treatment despite having 
the necessary tools, and is an important factor in why those therapies are commonly less 
effective than they should be in routine clinical practice (Waller & Turner, 2016, p. 129)”. 
This reduces the chance of improvement and is the result of human characteristics, including 
personality, knowledge, beliefs and safety behaviours. Therapist drift does not always occur 
consciously, but clients’ chance of improvement reduces as the intervention deviates from the 
protocol (Waller & Turner, 2016). Being supervised does not necessarily reduce therapist 
drift, as supervisory drift is also common (Waller & Turner, 2016). Nevertheless, a meta-
analysis to the effectiveness of implementing guidelines from RCTs in clinical practice shows 
improvements in results and quality of care (Grimsham & Russel, 1993). 
Besides, there is evidence that the results of RCT’s are not representative for clinical 
practice (Fonagy, 1999; Persons & Silberschatz, 1998; Roth & Parry, 1997). The effect of an 
intervention with an RCT design usually has a high internal validity, but a low external 
validity (Treweek & Zwarenstein, 2009; Van der Lem et al., 2012). This ensures unbiased 
causal effects, but the results can not be generalized to clinical practice as RCTs control 
variables and circumstances that can not be controlled in clinical practice (Bath et al., 2013). 
Differences include for example selection criteria to prevent comorbidity and low symptom 
intensity, the prevention of non-adherence and standardized settings (Van der Lem et al., 
2012). The study of Persons & Silberschatz (1999) argued upon the usefulness of RCT’s to 
psychotherapists. The most important strength of an RCT is that information about the 
comparative treatment efficacy can be acquired. This is useful for therapists in informing and 
recommending clients about different treatments and the gives them the assurance of 
providing evidence-based treatment. The weaknesses of an RCT include the provision of 
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generalized information about the average case instead of the unique cases therapists deal 
with in clinical practice (Persons & Silberschatz, 1998). Treatment protocols are often 
disorder-specific, which make them difficult to implement as many clients in clinical practice 
deal with comorbidities. In contrast to RCTs, treatment in clinical practice is not of fixed 
duration, not randomly assigned as clients can choose their therapist and focused on 
improving the general quality of life instead of single symptoms. Finally, treatment manuals 
do not include common barriers faced by therapists, including therapeutic relationship 
problems and noncompliance. Persons & Silberschatz (1998) therefore suggest the necessity 
of an increased external validity of RCTs by a more heterogenous sample and less exclusion 
criteria. Besides, a shifted focus to effectiveness studies and single case studies is needed, as 
these are more useful in providing valuable information to therapists. Yet, these naturalistic 
studies are not considered valid in proving the effectiveness of a therapy by the American 
Psychological Association (APA; Task Force on Promotion and Dissemination of 
Psychological Procedures, 1995). According to the pragmatic-explanatory continuum 
indicator summary (PRECIS), the level of efficacy, shown by explanatory RCTs, and 
effectiveness, shown by pragmatic research, can be tracked on a continuum of the two 
extremes (Thorpe et al., 2009). It is impossible to demonstrate both in the same study, as 
efficacy shows an effect under ideal circumstances and effectiveness in real-world conditions 
(Porzsolt et al., 2015). Therefore, Treweek & Zwarenstein (2009) suggested that first trials of 
a healthcare intervention should be small pilot trials. If this trial shows positive results, it is 
still unclear if the intervention will show similar results in clinical practice. Hence, research 
conducted with the clinicians and clients for whom the intervention is relevant in the 
uncontrolled clinical practice is necessary (Porzsolt et al., 2015; Treweek & Zwarenstein, 
2009). As RCTs are limited in generalizability, self-selected control conditions might cause 
biased results and a naturalistic pre-post test design provides insufficient evidence (Barth et 
al., 2013), the question is which design is the most suitable for psycho-oncological 
interventions. Hence, it is important to study the implementation of the evidence-based 
therapy in clinical practice and compare the results of both designs in reducing fatigue 
severity.  
The research question is as follows:  
Is Cognitive Behavioral Therapy in clinical practice effective in reducing cancer-
related fatigue in disease-free patients?  
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Hypothesis 1: It is expected that fatigue severity, as measured by the Checklist Individual 
Strength fatigue severity subscale, will decrease significantly after clients received CBT in 
clinical practice compared to before treatment. 
The negative consequences of fatigue as described above, can be divided into 
functional and psychological problems. Functional problems include role functioning, home 
management, work, mobility, alertness, sleep and rest, ambulation, social interactions and 
pastimes. Psychological problems include depression and anxiety, dysfunctional cognitions 
about fatigue, insufficient coping with the experience of cancer and fear of disease 
recurrence. As discussed above, some of the functional and psychological problems are 
considered to be perpetuating factors of post-cancer fatigue and therefore the target of CBT. 
The following sub questions are formulated:  
Is CBT in clinical practice effective in reducing functional impairment?  
Hypothesis 2: It is expected that functional impairment, as measured by the RAND-36, will 
decrease significantly after clients received CBT in clinical practice compared to before 
treatment. 
 
Is CBT in clinical practice effective in reducing psychological distress?  
Hypothesis 3: It is expected that psychological distress, as measured by the HADS, will 
decrease significantly after clients received CBT in clinical practice compared to before 
treatment. 
 
Is there a difference in effect of CBT on fatigue severity in clinical practice compared 
to the intervention in the RCT? 
Hypothesis 4a: It is expected that clients receiving CBT in clinical practice will have a 
similar or smaller decrease in fatigue severity, as measured by the Checklist Individual 
Strength fatigue severity subscale, than the clients in the intervention group from the RCT.  
 
Hypothesis 4b: It is expected that clients receiving CBT in clinical practice will have a 
greater decrease in fatigue severity, as measured by the Checklist Individual Strength fatigue 
severity subscale, than the clients in the control group from the RCT. 
 
According to the guidelines of the Fatigue Coalition, CRF consists of several components, 
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including cognitive deficiencies, decreased motivation and a low activity level (Murphy et 
al., 2006). Hence, there will be an exploratory look at the effect of CBT for pot-cancer fatigue 
on these components. 
 
 Is CBT in clinical practice effective in improving levels of motivation, concentration 
and activity? 
Hypothesis 5: It is expected that the clients’ level of motivation, concentration and activity, as 
measured by the Checklist Individual Strength motivation, concentration and activity 
subscales, will decrease significantly after clients received CBT in clinical practice compared 
to before treatment. 
 
According to the literature, contrary results are found for the influence of the demographic 
and treatment factors age, gender and type of treatment on post-cancer fatigue (Abrahams et 
al., 2016; Bischel et al., 2016; Gielissen et al., 2007; Kreissl et al., 2016; Miaskowski, 2004; 
Servaes et al., 2007). It is not clear yet if these factors have an effect on the psychological 
treatment of CRF. It might be expected that age, gender and type of treatment are 
contributing factors to the effect of CBT on post-cancer fatigue. To have an exploratory look 
on possible other contributing factors, the baseline characteristics (Table 1) will also be 
examined. 
 
Which demographic, disease and treatment factors are contributing to the effect of 
CBT on post-cancer fatigue?  
Hypothesis 6: It is expected that the factors age, gender and type of treatment will have a 
significant influence on the effect of CBT on post-cancer fatigue.  
 
2. Method 
2.1 Sample  
Between 2012 and 2017, data was collected from a sample of 50 disease-free cancer patients 
with somatically unexplained severe fatigue for at least six months after treatment that 
fulfilled the criteria of undifferentiated somatoform disorder (DSM-V) or somatic symptom 
disorder (DSM V). The patients received Cognitive Behavioral Therapy (CBT) for post-
cancer fatigue at the Helen Dowling Institute. All cancer diagnoses and treatments were 
included. Severe fatigue was defined as a score of 35 or higher on the Checklist Individual 
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Strength fatigue severity subscale. Participants who still received cancer treatment or 
experienced other psychological problems were excluded from the study. From the 50 
participants that started CBT, seven dropped out for different reasons. Four participants had a 
disease recurrence. Two participants were redirected because they did not fit the CBT for 
post-cancer fatigue protocol due to personality problems and ‘wait and see’ cancer treatment. 
One participant dropped out for an unknown reason, because of a no show. The remaining 44 
participants filled out the questionnaires at the pre- and post-test and were therefore eligible 
for this study. The sample consisted of 8 men and 35 women. Age ranged between 25 and 72 
with a mean of 51.7 (SD = 9.9). Other sample characteristics can be found in Table 1.  
 
Table 1. Baseline characteristics of participants in clinical practice and RCT 
 Clinical practice 
           
N        Range (M; SD)/% (N)    
RCT CBT  
(N = 50) 
M (SD)/% (N) 
RCT Waiting list 
(N = 48) 
M (SD)/% (N) 
Age  43 25-72 (51.7; 10) 44.6 (9.9) 45.3 (10.3) 
Gender 
     Female 
     Male 
43  
81.4% (35) 
18.6% (8) 
 
46% (23) 
54% (27) 
 
52.1% (25) 
47.9% (23) 
Education level (1=low to 7=high) 39 3.3-7 (6; 5.2-6)**** 4.4 (1.6) 4.3 (1.7) 
Marital status 
     Married/cohabiting 
     Unmarried 
     Divorced 
     Widowed 
43  
- 
- 
- 
- 
 
82% (41) 
12% (6) 
4% (2) 
2% (1) 
 
86% (41) 
8% (4) 
6% (3) 
- 
Living conditions* 
     Partner 
     Single 
     Children 
     Other 
43  
74.4% (32) 
21% (9) 
44.2% (19) 
4.7% (2) 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
Employment* 
     Work  
     Voluntary work 
     Full disability insurance act 
     Partial disability insurance act 
     Sick leave 
     School 
     Unknown 
43  
65.1% (28) 
9.3% (4) 
2.3% (1) 
2.3% (1) 
55.8% (24) 
- 
2.3% (1) 
 
54% (27) 
14% (7) 
28% (14) 
24% (12) 
10% (5) 
4% (2) 
- 
 
56% (27) 
8% (4) 
29% (14) 
33% (16) 
4% (2) 
6% (3) 
- 
Cancer diagnosis 
     Breast cancer 
     Testicular cancer 
     Hematologic cancer 
     Colorectal cancer 
     Other 
43  
58.1% (25) 
2.3% (1) 
18.6% (8) 
7% (3) 
14% (6) 
 
30% (15) 
24% (12) 
20% (10) 
- 
26% (13) 
 
31% (15) 
27% (13) 
13% (6) 
- 
29% (14) 
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Treatment type* 
     Surgery 
     Chemotherapy 
     Radiotherapy 
     Other 
43  
90.7% (39) 
69.8% (30) 
48.8% (21) 
4.7% (2) 
 
78% (39) 
60% (30) 
54% (27) 
- 
 
88% (42) 
85% (41) 
48% (23) 
- 
Duration of cancer treatment, 
months 
43 - 6.5 (6.8) 7.1 (6.0) 
Time since cancer treatment, 
years 
20 0.7-34 (2.6; 15-79.5)**** 5.5 (4.3) 4.6 (3.4) 
Primary outcome variable** 
     Fatigue severity 
     Functional impairment*** 
 
43 
43 
 
34-56 (46.1; 6) 
45-95 (72.3; 15.3) 
 
47.6 (6.5) 
1029.6 (504.9) 
 
47.3 (6.9) 
860.7 (485.5) 
Secondary outcome variables** 
     Psychological distress*** 
 
41 
 
6-34 (17.4; 6.2) 
 
143.6 (39.9) 
 
130.1 (23.5) 
Notes. * Percentages do not add up to 100% because more options are possible. 
** High scores in the RCT indicate a high level of fatigue, functional impairment and 
psychological distress. High scores in clinical practice indicate a high level of fatigue and 
psychological distress, but a low level of functional impairment. 
*** Functional impairment and psychological distress are measured using different 
questionnaires in clinical practice and RCT.  
**** Range (Mdn; IQR) 
2.2 Procedure 
The participants in this study were referred by their general practitioner for mental health care 
at the Helen Dowling Institute, a health care institution specialized in psycho-oncology. 
Therapy was given by five therapists, who were trained in CBT for post-cancer fatigue and 
supervised. After a telephone screening and intake, clients with undifferentiated somatoform 
disorder, i.e. severe unexplained post-cancer fatigue as the main problem were assigned to the 
CBT. Demographic and medical data was retrieved at the intake by self-report questionnaires. 
Moreover, participants filled out questionnaires regarding the perpetuating factors of post-
cancer fatigue, including ineffective coping with the experience, fear of disease recurrence, 
dysfunctional cognitions about fatigue, dysregulation of sleep, dysregulation of activity and 
low social support and negative social interactions (Gielissen et al., 2006). These 
perpetuating factors are challenged during therapy using the following cognitive and 
behavioral techniques:  
Insufficient coping with the experience of cancer: learning better coping strategies by 
using exposure techniques, including writing or talking about the stressful experience. 
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Fear of disease recurrence: challenging dysfunctional thoughts about the fear of 
disease recurrence against reality.  
Dysfunctional cognitions regarding fatigue: education about the precipitating and 
perpetuating factors and learning more helpful thoughts.  
Dysregulation of sleep: re-establishing a regular and biologic sleep-wake rhythm. 
Dysregulation of activity: clients that engage in longer periods of activity and rest 
need to learn how to pace activity to gradually increase their activity level. Clients that avoid 
activity due to the fear of fatigue need to start becoming active.  
Low social support and negative social interactions: learning clients to have realistic 
expectations of their social network.  
The results of the questionnaires indicated which factors were problematic and should 
be the focus of the therapy. A module is created for every perpetuating factor that can be 
added to the treatment plan. Hence, the main focus of the therapy was adjusted to the 
individual needs. The number and type of modules differed among the participants, but the 
content of each module was standardized. The amount of sessions was adjusted to the 
individual needs as well and varied between 5 and 34 sessions of 45 minutes (M = 10.9, SD = 
6.3). This depended on the number of modules and the improvement made by the client. The 
retrieved data was completed with information from the patients’ medical files and compared 
to the data from the RCT by Gielissen et al. (2006).  
 
2.3 Instruments  
To measure the primary dependent variable fatigue severity, the Checklist Individual Strength 
(CIS) fatigue severity subscale was used. This subscale contains eight statements on a 7-point 
Likert scale about the experience of fatigue in the past two weeks. To meet the inclusion 
criteria of severe fatigue, a score of 35 or higher was needed. Cronbach’s alpha for the 
subscale is 0.88 and convergent and discriminant validity are adequate (Vercoulen et al., 
1994). The remaining subscales motivation, concentration and activity were used to have an 
exploratory look on the effect of CBT. These subscales consist of respectively four, five and 
three items with Cronbach’s alpha’s of 0.83, 0.92 and 0.87 (Vercoulen et al, 1994). 
To measure the secondary dependent variable functional impairment, the RAND-36 
‘functional status’ was used. This subscale contains four dimensions, including functional 
status consists of the dimensions physical functioning, social functioning and physical and 
emotional role limitations. Higher scores on the RAND-36 indicate a reduced functional 
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impairment with an optimal score of 100 (Van der Zee & Sanderman, 1993). Cronbach’s 
alpha for the dimension physical functioning is .92 and for the dimension social functioning 
.71. Content, construct and criterion-related validity are adequate (Van der Zee & Sanderman, 
1993).  
The secondary dependent variable psychological distress was measured by the 
Hospital Anxiety and Depression Scale (HADS), which consists of an anxiety and depression 
subscale with a total of 14 self-report items. A score between 11 and 21 on the anxiety or 
depression subscale might indicate a disorder (Bjelland, Dahl, Haug & Neckelmann, 2002). 
Cronbach's alpha is .83 for the anxiety subscale and .82 for the depression subscale. 
Correlation between the subscales is .52 (Bjelland et al., 2002). Criteria and construct validity 
are adequate (Mitchell, Meader & Symonds, 2010). Both subscales will be used. 
 
2.4 Design 
For the first three hypotheses, the independent variable was the time of measurement, 
which was measured on nominal level and operationalized as pre- and post-treatment. Pre-
treatment test was the start of the CBT for hypothesis 1 and 2 and the moment of intake for 
hypothesis 3. Post-treatment test was not a fixed moment, but varied among the clients 
depending on their improvement. For the first hypothesis, the primary dependent variable was 
fatigue severity, which was measured on quasi-interval level with a cut-off score of 35 on the 
CIS fatigue severity subscale. For the second hypothesis, the dependent variable was 
functional impairment, which was measured on interval level and operationalized as the score 
on the RAND-36 functional status subscale. For the third hypothesis, the dependent variable 
was psychological distress, which was measured on quasi-interval level and operationalized 
as the HADS total score. A longitudinal study with a quasi-experimental one-group pre-test 
post-test design is used for the first three hypotheses. All three questionnaires were self-
assessed. For the fourth hypothesis, the independent variable was the condition in which 
clients receive CBT, which was measured on nominal level and operationalized as RCT or 
clinical practice. The dependent variable was also fatigue severity. A longitudinal quasi-
experimental non-equivalent groups design is used for the fourth hypothesis. For the fifth 
hypothesis, the independent variable is also the time of measurement. The dependent 
variables are level of motivation, concentration and activity, which are measured on quasi-
interval level and operationalized as the score on the CIS motivation, concentration and 
activity subscales. A longitudinal study with a quasi-experimental one-group pre-test post-
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test design is used for the fifth hypothesis. For the sixth hypothesis, the independent variables 
were the demographic factors age and gender and the treatment factor type of treatment. 
Gender and type of treatment were measured on nominal level and age on interval level. 
Gender was operationalized as male or female and type of treatment as surgery, 
chemotherapy, radiotherapy and/or hormonal therapy. The dependent variable was also 
fatigue severity. An exploratory study design was used for the last hypothesis.  
 
2.5 Treatment procedure  
As the intervention is implemented in clinical practice, the start and end of the CBT for post-
cancer fatigue were not always the same as the start and end of the complete psychological 
treatment at the Helen Dowling Institute. As shown in Figure 1, clients complete the HADS 
at the moment of intake, but the fatigue questionnaires CIS and RAND at the start of the CBT 
for post-cancer fatigue. Therefore, the moment clients filled out the HADS and the 
CIS/RAND varied over participants. The CIS and RAND-36 questionnaires filled out at T1 
and T2 were used in order to test hypothesis 1 and 2. To test hypothesis 3, the HADS filled 
out at T0 and T3 were used.  
 
 
Figure 1. Treatment program and times of measurement at the Helen Dowling Institute 
 
T1 to T2 ranged between 1 and 35 months (M = 6.4; SD = 5.7). The 43 participants 
received between 6 and 34 therapy sessions (M = 11.7, SD = 5.7). The data from eight 
participants is missing. T0 to T1 ranged between -3 and 27 months (M = 3.6; SD = 6.6), as 
some participants filled out the CIS and RAND-36 before the HADS. Twelve participants 
received therapy prior to CBT for post-cancer fatigue, which ranged from 1 to 246 sessions 
(T0 - T1; Mdn = 13.0, IQR = 4-41.5). This wide range is an example of the differences 
between an RCT and a study in clinical practice, as comorbidities are not excluded in clinical 
practice. One client received 246 sessions due to relapses and many comorbidities including 
 
HADS CIS 
RAND-36 
CIS  
RAND-36 
HADS 
T0 T1 T2 T3 
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post-traumatic stress disorder, personality disorder and problems with partner, work and 
finances. The types of therapy that the twelve participants received prior to CBT included 
group therapy and cognitive-behavioural therapy for depression and anxiety. Other 
participants were on the waiting list between one and twelve weeks after the intake (T0-T1; 
M = 3.4, SD = 3.2). T2 to T3 ranged between -6 and 9 months (M = 1.6; SD = 2.9), as some 
participants filled out the HADS before the CIS and RAND-36. Seven participants continued 
therapy after the CBT for post-cancer fatigue finished, which ranged from 7 to 27 sessions 
(T2 - T3; M = 1.4, SD = 4.7). One participant currently receives therapy. The types of therapy 
included group therapy and CBT for anxiety and stress. Finally, six participants received 
systemic, group or eye movement desensitization and reprocessing (EMDR) therapy besides 
CBT, which ranged from two to nine sessions (M = 6.5, SD = 2.4).  
 
2.6 Statistical analyses 
According to the power analysis, a sample of 38 was needed to reach a significance of 5% 
(two-tailed), power of 85% and effect size of 0.25 (Faul, Erdfelder, Lang & Buchner, 2007). 
The results were analysed using the Statistical Package for the Social Sciences (SPSS) 20 on 
an intention-to-treat basis. Missing data would ideally be completed by imputation. However, 
the missing values exceeded the limit of 25% per questionnaire and could therefore not be 
completed by imputation. Therefore, missing data was handled by carrying the last 
observation forward, as the same method was used by Gielissen et al. (2006). The 
consequence of carrying the last observation forward is that it affects the results as neither 
improvement will be assumed, nor deterioration. This method was used for 18 participants.  
To test hypotheses 1, 2 and 3, one-way repeated measures analysis of variance 
(ANOVA) was used. To test hypothesis 4, a manual independent samples t-test was used. To 
test hypothesis 5, one-way repeated measures ANOVA was used.  To test hypothesis 6, a 
multiple regression analysis was performed to reveal predictors for the post-test scores on the 
CIS fatigue severity subscale. Criteria for significance was p < .05.  
Finally, the clinically significant improvement of the participants was determined. 
Based on the RCT, a clinically significant improvement is determined by reference to the 
reliable change index and the normative range (Gielissen et al., 2006). To test whether a 
significant change in fatigue was meaningful, the reliable change index was calculated 
(Jacobson  & Truax, 1991). Any score more than 1.96 indicated a reliable change that can not 
be accounted to an imprecise measuring instrument (Jacobson  & Truax, 1991). If scores also 
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decreased to a normal range, there has been a clinically significant improvement. The normal 
range was defined as any score below one standard deviation above the mean of a normative 
group, as values within the range of one standard deviation of the mean are statistically 
considered to be normal distributed (Gielissen et al., 2006). This group consisted of 93 non-
fatigued breast cancer survivors (Servaes et al., 2002). Normal range was a score below 30.4 
on the CIS (Servaes et al., 2002).  
 
2.7 Randomized Controlled Trial 
For hypothesis 4, the effects of the intervention in clinical practice were compared to the 
effects of the intervention in the RCT from Gielissen et al. (2006). The intervention in 
clinical practice is based on the RCT, but differs in certain methodological factors. Hence, the 
method that was used in the RCT will be briefly described below.  
 
2.7.1 Sample of previous RCT 
A sample of 112 disease-free cancer patients were eligible to enter the RCT. Before starting, 
they were screened and excluded on any other relevant diseases and comorbidities. Scores on 
the CIS fatigue severity subscale at screening for entrance into the trial were also used as 
baseline assessment. Besides, patients that received any psychological treatment were 
excluded. The patients had to be finished with curative treatment at least one year before the 
start of the study. Subsequently, 98 participants remained and were intended to treat. Age 
ranged between 18 and 65 years. Other sample characteristics can be found in Table 1 
(Gielissen et al., 2006). Finally, 13 participants dropped out before the second assessment.   
 
2.7.2 Procedure of previous RCT 
The procedure of the RCT was similar to clinical practice described above. Differences 
include the use of random assignment to an intervention group or control group. The amount 
of sessions ranged between 5 and 26 sessions (M = 12.5, SD = 4.7) of one hour for six 
months. Participants were offered two follow up sessions after another six months.  
  
2.7.3 Instruments of previous RCT 
To measure the primary dependent variable fatigue severity, the CIS fatigue severity subscale 
was used. To measure the primary dependent variable functional impairment, the Sickness 
Impact Profile-8 (SIP-8) was used. This scale consists of twelve subscales, including 
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sleep/rest, eating, work, home management, recreation and pastimes, ambulation, mobility, 
body care and movement, social interactions, alertness behavior, emotional behavior and 
communication (Bergner, Bobbitt, Carter & Gilson, 1981). The secondary dependent variable 
psychological distress was measured by the Symptom Checklist 90 (SCL-90). This scale 
consists of 90 items scored on a 5-point Likert scale and measures anxiety, agoraphobia, 
depression, somatization, hostility, insufficiency of thinking and acting, interpersonal 
sensitivity and sleep problems (Rosen et al., 2000). 
 
2.7.4 Design of previous RCT 
In contrast to the clinical practice, the RCT used fixed times of measurement at baseline and 
after six months. The independent variable was the condition, which was measured on 
nominal level and operationalized as CBT condition or waiting list condition. The primary 
dependent variable fatigue severity was measured with the same cutoff score of 35 on the CIS 
fatigue severity subscale. The secondary dependent variable functional impairment was 
measured on interval level and operationalized as the score on the SIP-8. The secondary 
dependent variable psychological distress was measured on interval level and operationalized 
as the score on the SCL-90.  
 
2.7.5 Statistical analyses of previous RCT 
Analyses in the RCT were conducted on an intention-to-treat basis. Missing data was handled 
by carrying the last observation forward. ANOVA was used to test differences between the 
conditions. Finally, the clinically significant improvement was calculated.  
 
3. Results 
Boxplots indicated two univariate outliers in the CIS and HADS difference scores, which 
were considered acceptable. These scores were not excluded as they were both from the same 
client who had a major but not impossible improvement. The therapist verified that it was a 
valid and reliable result. No other univariate and bivariate outliers have been identified before 
further analyses.  
 For hypothesis 1, boxplots and Shapiro-Wilk statistics indicated that the assumption 
of normality was supported. Fmax was 3.617, demonstrating homogeneity of variances and 
Mauchly’s test indicated that the assumption of sphericity was not violated as there are only 
two measurements. A one-way repeated measures ANOVA indicated that the clients’ scores 
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on the CIS fatigue severity subscale did decrease significantly, F (1, 42) = 65.13, p < .001, 
partial η2 = .608. Cohen’s d = 1.51, indicating a large effect size (Cohen, 1988).  
For hypothesis 2, assumptions for homogeneity of variances and sphericity were not 
violated. However, Shapiro-Wilk statistics indicated that the assumption of normality was 
violated. As transformation did not correct the assumption, a Friedman two-way ANOVA 
was used. This analysis indicated that the scores on the RAND-36 did increase significantly 
between the pre- and post-test, 2F = 8.07, df = 1, N - Ties = 33, p = .005.  
The one-way repeated measures ANOVA for hypothesis 3 indicated that the clients’ 
scores on the HADS did decrease significantly,  F (1, 40) = 64.07, p < .001, partial η2 = .616. 
Cohen’s d = 1.11, indicating a large effect size (Cohen, 1988). 
The results of the intervention in clinical practice on fatigue severity, functional 
impairment and psychological distress compared to the intervention in the RCT can be found 
in Table 3.  
 
Table 3. Effect of Cognitive Behavioral Therapy on Fatigue Severity, Functional Impairment, 
and Psychological Distress 
 N T0 
M (SD) 
T1 
M (SD) 
T2*** 
M (SD) 
T3 
M (SD) 
Treatment effect  
(95% CI)**** 
p-value 
***** 
Fatigue severity 
RCT Waiting list 
RCT CBT 
Clinical practice 
 
48 
50 
43 
  
47.3 (6.9) 
47.6 (6.5) 
46.1 (6.0) 
 
42.1 (9.6) 
29.0 (14.9) 
32.4 (11.3) 
  
 
13.3 (8.6 to 18.1) 
 
 
 
.000 
.000 
Functional 
impairment* 
RCT Waiting list  
RCT CBT 
Clinical practice** 
 
 
46 
50 
33 
  
 
860.7 (485.5) 
1029.6 (504.9) 
73.0 (15.8) 
 
 
821.7 (524.3) 
607.4 (578.9) 
77.8 (13.7) 
  
 
 
383.2 (197.1 to 569.2) 
 
 
 
 
.000 
.071 
Psychological 
distress* 
RCT Waiting list  
RCT CBT 
Clinical practice 
 
 
46 
50 
41 
 
 
 
 
17.4 (6.2) 
 
 
130.1 (23.5) 
143.6 (39.9) 
 
 
 
131.2 (28.9) 
123.2 (36.3) 
 
 
 
 
 
10.3 (6.6) 
 
 
 
21.6 (12.7 to 30.4) 
 
 
 
 
.000 
.000 
 
       
Notes. * The questionnaires used in the RCT and clinical practice differ 
**  higher scores on the RAND-36 indicate a reduced functional impairment 
***T2 in the RCT conditions was at 6 months, T2 in clinical practice depended on 
improvement of the client and ranged between 1 and 35 months (M = 6.4, SD = 5.7) 
**** Treatment effect of RCT CBT compared to RCT Waiting list 
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***** p-value of the RCT indicates significance between the conditions, p-value of clinical 
practice indicates significance between pre- and post-test 
 
For hypothesis 4, a manual independent samples t test was used to compare the scores 
on the CIS fatigue severity subscale of the participants in both the intervention (n = 50) and 
waiting list (n  = 48) condition of the RCT with the intervention in clinical practice (n = 43). 
As the standard deviation of the difference scores of the RCT conditions are unknown, 
analysis was conducted using post-test scores. In advance, a manual independent samples t 
test was used to test whether the baseline scores of the conditions in the RCT and clinical 
practice were equal. However, the results showed that the RCT did not have significant 
higher baseline scores. The t test for post-test scores was statistically significant as well, with 
the participants in the RCT intervention condition (M = 29.0; SD = 14.9) reporting post-test 
scores of 3.4 points lower on the CIS fatigue severity subscale than the participants in clinical 
practice (M = 32.4; SD = 11.3), t(91) = -4.50, one-tailed, d = 0.26. The second t test was 
statistically significant as well, with the participants in the RCT waiting list condition (M = 
42.1; SD = 9.6) reporting post-test scores of 9.7 points higher than the participants in clinical 
practice, t(89) = 13.9, one-tailed, d = 0.93. To test whether the intervention caused a 
clinically significant improvement, the reliable change index and normal range were 
calculated (Table 4).  
 
Table 4. Clinically significant improvement of fatigue severity, functional impairment and 
psychological distress  
 Post-test*** 
% (n) improved 
Reliable Change Index 
only 
Post-test*** 
% (n) improved 
Normative range 
only 
Post-test*** 
% (n) improved 
Total clinically significant 
improvement 
Fatigue severity* 
RCT waiting list 
RCT CBT 
Clinical practice 
 
 
 
16.3% (7)                            46.5% (20) 
 
4% (2)  
54% (27) 
14% (6) 
Functional impairment** 
RCT waiting list 
RCT CBT 
Clinical practice 
 
 
 
4.7% (2) 
 
18% (18) 
50% (25) 
Psychological distress**   
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RCT waiting list 
RCT CBT 
Clinical practice 
 
 
39.5% (17) 
 
 
 
 
  
Notes.*  Reliable change index > 1.96 and normative range cut-off score of Checklist 
Individual Strength fatigue severity subscale < 30.4 
** Reliable change index > 1.96 
*** Post-test RCT = after 6 months, post-test fatigue severity and functional impairment = 
T2, post-test psychological distress = T3 
 
For hypothesis 5, additional one-way repeated measures ANOVA for the CIS 
subscales indicated that the scores for activity,  F (1, 42) = 33.84, p < .001, partial η2 = .446; 
motivation,  F (1, 42) = 20.89, p < .001, partial η2 = .332 and concentration,  F (1, 42) = 
18.70, p < .001, partial η2 = .308 did improve significantly. Cohen’s d’s are respectively 0.92, 
0.59 and 0.61, indicating large effect sizes (Cohen, 1988).  
To test hypothesis 6, a standard multiple regression analysis (MRA) was performed to 
estimate the proportion of variance in the post-test score on the CIS fatigue severity subscale 
that can be predicted by age, gender and type of treatment. Prior to interpreting the results, 
the assumptions of normality, linearity, homoscedasticity, outliers and multicollinearity were 
checked. The factors age, gender and type of treatment did not have as significant influence 
on the effect of CBT on post-cancer fatigue. The MRA revealed no other significant 
predictors among the baseline characteristics.  
4. Discussion 
The aim of the study was to examine whether Cognitive Behavioral Therapy (CBT) in 
clinical practice is effective in reducing post-cancer fatigue and whether it is as effective as 
the intervention tested in the RCT (Gielissen et al., 2006). This is the first study to evaluate 
the effectiveness of this therapy in clinical practice. According to the results, CBT seems 
effective in reducing post-cancer fatigue in clinical practice. Besides, clients receiving CBT 
in clinical practice had a larger improvement compared to the clients in the waiting list 
condition of the RCT, but less improvement than the clients receiving the intervention in the 
RCT.  
 According to the first hypothesis, it was expected that fatigue severity, as measured 
by the Checklist Individual Strength fatigue severity subscale, would decrease significantly 
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after clients received CBT in clinical practice compared to before treatment. This hypothesis 
was confirmed as the results indicated a significant decline of the scores on the CIS fatigue 
severity subscale with a large effect size. This result has been expected according to the 
literature, as an improvement in fatigue severity was also found among survivors with post-
cancer fatigue (Gielissen et al., 2006) and severely fatigued cancer patients (Servaes et al., 
2002; Kangas et al., 2008). A limitation includes the different times of measurement, as many 
participants received additional therapy or were on the waiting list. Hence, it can not be 
excluded that the results might be partly caused by different factors than the therapy, 
including spontaneous recovery. However, spontaneous recovery of fatigue severity hardly 
occurs, as shown in studies with waiting list control groups (Bower et al., 2015; Johns et al., 
2015; Gielissen et al., 2006; Kreissl et al., 2016). Besides, compared to the effects of the 
waiting list condition of the RCT, the effects in clinical practice are significantly larger.  
 According to the second hypothesis, it was expected that functional impairment, as 
measured by the RAND-36, would decrease significantly after clients received CBT in 
clinical practice compared to before treatment. This hypothesis was confirmed as the results 
indicated a significant increase of scores on the RAND-36. This result has been expected 
according to the literature, as functional impairment was found to be a dimension of fatigue 
in cancer survivors (Servaes et al., 2002) and an improvement in functional impairment 
among cancer survivors by the same therapy was also found in the previous RCT (Gielissen 
et al., 2006). However, a limitation with regard to this analysis is the large amount of missing 
data and small sample for the RAND-36. The pre-test scores of eleven participants were 
missing and therefore excluded from the analysis. Yet, a significant improvement was found 
in spite of the high scores at the pretest of the remaining participants. This indicates that 
clients had little functional impairment at the start of the treatment, which means there was 
little room for improvement.  
 According to the third hypothesis, it was expected that psychological distress, as 
measured by the HADS, would decrease significantly after clients received CBT in clinical 
practice compared to before treatment. This hypothesis was confirmed as results showed a 
significant decline of scores on the HADS with a large effect size. This result has been 
expected according to the literature, as psychological distress was found to be a dimension of 
fatigue in cancer survivors (Servaes et al., 2002) and an improvement in psychological 
distress among cancer survivors by the same therapy was also found in the previous RCT 
(Gielissen et al., 2006). However, as psychological distress is measured by the HADS at T0 
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and T3, the scores might have been influenced by pre- or post-treatments or other external 
factors while on the waiting list. Further research could focus on the possibility that 
functional impairment and psychological distress are mediators of fatigue severity. Clients 
sought psychological help for the persistent severe fatigue, but their functional impairment 
and psychological distress reduced as well. This raises the question if the reduction of fatigue 
severity depends on functional impairment and psychological distress or the other way 
around.  
According to the fourth hypothesis, it was expected that clients receiving CBT in 
clinical practice would have a similar or less significant decrease in fatigue severity, as 
measured by the Checklist Individual Strength fatigue severity subscale, than the clients in 
the intervention group from the RCT, but a greater decrease in fatigue severity than the 
clients in the control group from the RCT. The hypothesis was confirmed, as the participants 
in clinical practice showed significant lower scores at the post-test than the participants in the 
RCT CBT condition. Additionally, the participants in clinical practice showed significant 
higher scores at the post-test than the participants in the RCT waiting list condition. The 
results are in accordance with the expectations based on the differences in effect sizes 
between an RCT and clinical practice (Van der Lem et al., 2012). The use of stricter selection 
criteria in the RCT is apparent from the non-significant but higher scores at baseline 
compared to clinical practice. Since the RCT used the fatigue severity score as selection 
criterion for entrance into the study as well as baseline assessment, this might also have led to 
a slightly higher baseline score. The intervention in clinical practice is based on the protocol 
used in the RCT to ensure effectiveness and efficiency. However, therapist drift might have 
occurred and might explain the smaller effect size found in clinical practice (Waller & 
Turner, 2016). One known example of deviation of the protocol is the moment of setting 
goals. The guideline instructs to set goals at the beginning of the therapy, but some of the 
therapists have postponed this to a later stage as clients gained better insight in the feasibility 
of their goals at that point. It would be expected that this deviation has a positive effect on the 
therapy and therefore hardly an explanation for the smaller effect size in clinical practice. 
Besides, the smaller effect size could be explained by the existence of comorbidity in clinical 
practice and clients receiving additional psychological treatments. Eight participants scored at 
the pre-test above 22 on the HADS, which might indicate a depressive or anxiety disorder 
(Bjelland et al., 2002). Fourteen participants received additional therapy before, after or 
during CBT. 
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 Despite the fact that the current study was based on the RCT of Gielissen et al. 
(2006), there are differences in the samples of both studies that might explain the differences 
in effect size (Table 1). First, the proportion of males and females in the RCT was almost 
equal, while there were more women in clinical practice who have been found to experience 
more often and more severe fatigue (Kreissl et al., 2016; Miaskowski, 2004). This is 
associated with the large amount of breast cancer survivors and small amount of testicular 
cancer survivors in clinical practice compared to the RCT. In addition, participants in clinical 
practice had a higher education level, more time since treatment, went more often on sick 
leave and received less often disability insurance. The average age of the participants in 
clinical practice was higher. This could explain the differences in fatigue severity between the 
RCT and clinical practice, as older cancer patients were found to experience a lower level of 
fatigue (Bischel et al., 2016). Duration of cancer treatment was not included in clinical 
practice.  
Differences also existed in the methods of both studies. The study in clinical practice 
had a smaller sample size, higher age range and no exclusion based on comorbidity, 
psychological treatment and time since treatment. The therapy sessions in the RCT varied 
between 5 and 26 sessions within six months, with one or two optional follow-up sessions 
after another six months. The therapy sessions in clinical practice varied between an even 
bigger range of 5 and 34 sessions without time constraints and follow-up sessions. In contrast 
to the RCT, the study in clinical practice did not use fixed times of measurement to 
objectively compare the results. Besides, the study in clinical practice used four different 
times of measurement as many participants received additional therapy or were on the 
waiting list, which makes it hard to attribute any improvement directly to the intervention. 
Due to these differences, it is important to be cautious in comparing the RCT and clinical 
practice and interpreting the results. It is impossible to determine if other factors might have 
caused the lower effect size.  
According to the fifth hypothesis, it was expected that the demographic factors age 
and gender and the treatment factor type of treatment would have a significant influence on 
the effect of CBT on post-cancer fatigue. No predictors for the post-test score on the CIS 
fatigue severity subscale have been found, which is in accordance with the arbitrary results of 
most studies on contributing demographic, social and medical factors (Abrahams et al., 2016; 
Kuhnt et al., 2009; Okuyama et al., 2000; Servaes et al., 2002). An explanation for the lack of 
a significant predictor could be the small sample of the study. 
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According to the last hypothesis, it was expected that the clients’ level of motivation, 
concentration and activity would decrease significantly after clients received CBT in clinical 
practice compared to before treatment. The results showed a significant decline in the scores 
on the remaining CIS subscales, which means an improvement in the level of motivation, 
concentration and activity. This is in accordance with the literature suggesting the multiple 
components of CRF (Gielissen et al., 2006; Murphy et al., 2006). 
With regard to the clinically significant improvement of fatigue severity in clinical 
practice, 46.5% of the clients improved to the normal range. However, as only 16.3% had an 
improvement with a reliable change index, the total amount of clients with a clinically 
significant improvement was six. Zero clients had a clinically significant deterioration on 
fatigue severity and psychological distress, but one client had a deterioration with a reliable 
change index on functional impairment. Compared to the RCT, the clinically significant 
improvement of the clients in the current study was significantly less than the results of the 
intervention condition and not significantly better than the results of the waiting list 
condition. The small amount of clinically significant improved clients might be caused by the 
strict conditions of the reliable change index, which are only met by seven clients. This raises 
the question whether this method is useful in assessing the effectiveness of an intervention in 
clinical practice. The presence of comorbidities complicate attaining improvements that are 
large enough to meet the reliable change index. Improvements in the secondary outcome 
variables functional impairment and psychological distress were only measured on the basis 
of the reliable change index, due to the lack of data to define the normal range. The 
improvement in functional impairment of only two clients might be attributable to the 
intervention instead of an imprecise measurement. For psychological distress, the number of 
participants with a reliable change was 17.  
As the current study was conducted in clinical practice, it has several limitations. 
These include the lack of a control group and a follow-up measurement. Therefore, it is 
unknown if other factors might explain the effects of the intervention. However, as the 
efficacy of CBT has been shown in the RCT and the effect size of the therapy in clinical 
practice is significantly larger than the waiting list condition of the RCT, the effectiveness 
can be assumed. A final limitation was the method of dealing with missing data by carrying 
the last observation forward. This is a conservative method, as it assumes neither 
improvement, nor deterioration in participants’ scores. This method was used for 18 
participants on different questionnaires, which is a relatively large amount. 
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Despite the limitations, this study provides relevant information about the 
effectiveness of CBT for post-cancer fatigue in clinical practice. The increasing cancer 
survival rates, lack of somatic explanations and many adverse effects of post-cancer fatigue 
show the importance of a psychological intervention. Further research should therefore focus 
on the long term effects of the intervention in clinical practice conducted with a larger and 
more diverse sample with regard to gender, age and diagnosis. When comparing the current 
sample with the population of cancer survivors in the Netherlands and generalizing the 
results, differences in age exist. Only four clients older than 65 participated in clinical 
practice. As almost half of the cancer patients are diagnosed after the age of 65 (Gielissen et 
al., 2006), the proportion of clients above and below 65 years is not comparable to the entire 
population. However, these patients might not need the intervention as much as younger 
patients, since they do not have to work. Besides, it would be interesting to test whether the 
perpetuating factors of post-cancer fatigue are mediating the decrease of fatigue severity, by 
assessing the decrease of the perpetuating factors at the post-test in further research. Finally, 
the influence of therapist drift on the differences in effect size between the RCT and clinical 
practice should be examined. 
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